Why Did Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) Fall 13% in August?

Why is Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) a good investment after the recent pullback?

edit Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) fell over 13% in August 2019. This ETF has returned -25% in the last three months and -19% in the last six months. HMMJ’s top holdings include Aurora Cannabis (TSX:ACB)(NYSE:ACB), Canopy Growth (TSX:WEED)(NYSE:CGC), and Cronos Group (TSX:CRON)(NASDAQ:CRON).

Aurora Cannabis accounts for 10.3% of HMMJ, followed by Canopy Growth at 9.4% and Cronos at 8.8%. The top three holdings account for 28.5% of the ETF and are primary drivers of HMMJ’s stock price. So, let us see how each of these stocks have performed last month.

Aurora Cannabis

Shares of Aurora Cannabis fell 11.4% in August 2019. The stock has lost close to 41% since April 22 this year and has burnt significant investor wealth. Aurora declined in August due to an overall weakness in the cannabis industry. The cannabis stocks were rocked by CannTrust’s scandal and underwhelming results of Canopy Growth last month.

Investors are also wary about Aurora’s cash burn driven by its aggressive expansion efforts. There are enough encouraging signs for investors though. Analysts expect Aurora’s sales to rise by 370% in 2019 and 174% in 2020. They have an average target price of $13.23 for the stock, indicating upside potential of 81% from the current price.

Canopy Growth

Canopy Growth lost 25% last month. While it beat analyst earnings and revenue estimates in the fiscal first quarter of 2020 (ended in June), analysts were unimpressed by expanding losses. Canopy Growth posted a loss of $1.28 billion in the first quarter.

Similar to other cannabis companies, Canopy too is targeting aggressive growth via acquisitions. It acquired Acreage Holdings — a vertically integrated cannabis company — for $3.4 billion in April.

Canopy shares also fell last week when its largest investor Constellation Brands estimated a loss of $54 million in the August quarter. Constellation attributed this loss to its investment in Canopy Growth. Constellation has increased its stake in Canopy from 10% in 2017 to 35.6% in 2019.

Canopy shares have now fallen over 50% since the start of May this year and are trading at a discount of 81% to average analyst price target estimates of $56.67.

Cronos Group

Shares of Cronos Group fell 19.5% last month. This stock was negatively impacted, as it continues to trade at a hefty premium. The overall weakness in the cannabis sector has driven stock price lower in the last few months. Cronos is valued at $5 billion, which is 114 times its 2019 sales. This valuation is insanely high, despite its expected revenue and earnings-growth rates.

Cronos investors have lost over 50% since March 2019, and despite this pullback, analysts have an average target price of $15.28 for the stock. Cronos shares are trading at $14.6, implying upside potential of just 4.7% which is not attractive at all for cannabis investors.

What next for HMMJ investors?

It’s very likely that HMMJ will gain in market value in the coming months and end 2019 at a higher price. We have seen that two of its three top holdings have significant upside potential and will drive the ETF higher heading into 2020.

The growth story for cannabis stocks is far from over, and HMMJ investors are likely to benefit from the expansion efforts of several companies. Further, this ETF also provides a dividend yield of 5.5%, which is impressive.

A diversified, high-growth ETF with an attractive dividend yield makes for an enviable investment.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »